Eli Lilly has been selling pills to sick people for 150 years. That business model has made it a trillion-dollar company. But now, the firm’s CEO David Ricks wants to do something different. He wants to push treatments that stop people getting sick in the first place. Will it work?
Guests and hosts:
Topics covered:
Transcripts of our podcasts are available via economist.com/podcasts.
Listen to what matters most, from global politics and business to science and technology—subscribe to The Economist.
","author_name":"The Economist"}